| scholarly article | Q13442814 |
| P2093 | author name string | Edward J Cone | |
| David L Black | |||
| Melinda K Shelby | |||
| Yale H Caplan | |||
| Frank Moser | |||
| Tim Robert | |||
| P433 | issue | 1 | |
| P921 | main subject | gravity | Q11412 |
| P304 | page(s) | 1-7 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Journal of Analytical Toxicology | Q1709826 |
| P1476 | title | Normalization of urinary drug concentrations with specific gravity and creatinine | |
| P478 | volume | 33 |
| Q48178882 | A Very Unusual Accidental Mechanical Asphyxia of Choking with a Whole Solea Solea |
| Q28387509 | A dose-response study of arsenic exposure and markers of oxidative damage in Bangladesh |
| Q37569320 | A metabolic biosignature of early response to anti-tuberculosis treatment |
| Q49161955 | A validated UHPLC-MS/MS method to quantify low levels of anabolic-androgenic steroids naturally present in urine of untreated horses |
| Q89031810 | Adjusting urinary chemical biomarkers for hydration status during pregnancy |
| Q36048730 | Assessing urinary flow rate, creatinine, osmolality and other hydration adjustment methods for urinary biomonitoring using NHANES arsenic, iodine, lead and cadmium data |
| Q57186462 | Associations between prenatal maternal urinary concentrations of personal care product chemical biomarkers and childhood respiratory and allergic outcomes in the CHAMACOS study |
| Q64137611 | Associations of maternal exposure to triclosan, parabens, and other phenols with prenatal maternal and neonatal thyroid hormone levels |
| Q92491804 | Bisphenol A in human saliva and urine before and after treatment with dental polymer-based restorative materials |
| Q35763105 | Can we trust untargeted metabolomics? Results of the metabo-ring initiative, a large-scale, multi-instrument inter-laboratory study. |
| Q48819358 | Changes in acute biochemical markers of inflammatory and structural stress in rugby union |
| Q64130291 | Correlation of creatinine- and specific gravity-normalized free and glucuronidated urine cannabinoid concentrations following smoked, vaporized, and oral cannabis in frequent and occasional cannabis users |
| Q39134293 | Creatinine and specific gravity normalization in biological monitoring of occupational exposures. |
| Q57054562 | Creatinine excretion in consecutive urine samples after controlled ingestion of water |
| Q48335497 | Creatinine in urine - a method comparison. |
| Q38154663 | Demystifying analytical approaches for urine drug testing to evaluate medication adherence in chronic pain management |
| Q35868798 | Development and Validation of a GC-MS Method for the Detection and Quantification of Clotiapine in Blood and Urine Specimens and Application to a Postmortem Case |
| Q40705097 | Fenofibric Acid Can Cause False-Positive Urine Methylenedioxymethamphetamine Immunoassay Results. |
| Q57653689 | Global urine fingerprinting by LC-ESI(+)-HRMS for better characterization of metabolic pathway disruption upon anabolic practices in bovine |
| Q37401192 | High-resolution metabolomics of occupational exposure to trichloroethylene |
| Q41752155 | Influence of body mass index status on urinary creatinine and specific gravity for epidemiological study of children |
| Q43037011 | Involvement of urinary proteins in the rat strain difference in sensitivity to ethylene glycol-induced renal toxicity |
| Q37721920 | LC-MS: a powerful tool in workplace drug testing |
| Q46935052 | Lack of glucuronidation products of trans-resveratrol in plasma and urine of cats |
| Q31158476 | Longitudinal study of long-term smoking behaviour by biomarker-supported determination of exposure to smoke |
| Q42639893 | Marijuana and workplace safety: an examination of urine drug tests. |
| Q38424072 | Mass spectrometric based approaches in urine metabolomics and biomarker discovery |
| Q91576367 | Maternal and fetal exposures to fluoride during mid-gestation among pregnant women in northern California |
| Q58600975 | Prenatal high molecular weight phthalates and bisphenol A, and childhood respiratory and allergic outcomes |
| Q33571535 | Quantification of a methadone metabolite (EDDP) in urine: assessment of compliance |
| Q87418607 | Quantifying cobalt in doping control urine samples--a pilot study |
| Q38854170 | Realising the Potential of Urine and Saliva as Diagnostic Tools in Sport and Exercise Medicine. |
| Q28385894 | Renal function is associated with indicators of arsenic methylation capacity in Bangladeshi adults |
| Q51306338 | Requirement for specific gravity and creatinine adjustments for urinary steroids and luteinizing hormone concentrations in adolescents. |
| Q35799755 | Serial Free Bisphenol A and Bisphenol A Glucuronide Concentrations in Neonates |
| Q48101168 | Urinary L-FABP as a marker of vesicoureteral reflux in children: could it also have a protective effect on the kidney? |
| Q28393967 | Urinary arsenic profiles reveal exposures to inorganic arsenic from private drinking water supplies in Cornwall, UK |
| Q34659504 | Urinary diazepam metabolite distribution in a chronic pain population |
| Q56834525 | Urinary trace element concentrations in environmental settings: is there a value for systematic creatinine adjustment or do we introduce a bias? |
| Q51825946 | Urine Creatinine Concentrations in Drug Monitoring Participants and Hospitalized Patients. |
| Q30811482 | Variability in metabolism of imipramine and desipramine using urinary excretion data |
Search more.